QIAGEN and LabCorp deepen relationship with widespread use of bioinformatics solutions
(WorldNews Netherlands)

Hilden, Germany, and Germantown, Maryland, November 20, 2019 -QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an agreement with LabCorp® (NYSE: LH) to extend their current QIAGEN Clinical Insights (QCI) license with QIAGEN`s Human Gene Mutation Database (HGMD) of human genetic variants, the world`s largest database of inherited disease mutations. This agreement builds on the existing seven-year relationship between the two companies to develop, introduce and support new diagnostic tests. LabCorp will use HGMD across its network of laboratories to improve identification and interpretation of genetic variants within inherited diseases. `Next-generation sequencing has...